High-throughput screening
FGen’s NLR technology enables phenotypic screening and analysis under relevant conditions, including fed-batch cultivation and defined environments.
Source: LinkedIn company description · Retrieved October 13, 2026
FGen is a Swiss company combining biological engineering with high-throughput screening.
The company designs and optimizes cells for biotechnological applications. Its NLR technology enables analysis under conditions such as fed-batch cultivation and defined environments.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
FGen collaborates with industrial partners in industrial biotechnology, life sciences, and pharmaceuticals.
FGen’s NLR technology enables phenotypic screening and analysis under relevant conditions, including fed-batch cultivation and defined environments.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 5, 2026, September 6, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 26, 2026, September 30, 2026, October 7, 2026 and October 9, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.